112 related articles for article (PubMed ID: 2949917)
41. Urinary albumin excretion and transcapillary escape rate of albumin in malignancies.
Pedersen LM; Terslev L; SŁrensen PG; Stokholm KH
Med Oncol; 2000 May; 17(2):117-22. PubMed ID: 10871817
[TBL] [Abstract][Full Text] [Related]
42. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
Parving HH
Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
[TBL] [Abstract][Full Text] [Related]
43. Transcapillary filtration of plasma protein in long-term type 1 (insulin dependent) diabetic patients.
Kofoed-Enevoldsen A; Bent-Hansen L; Deckert T
Scand J Clin Lab Invest; 1992 Nov; 52(7):591-7. PubMed ID: 1455150
[TBL] [Abstract][Full Text] [Related]
44. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
[TBL] [Abstract][Full Text] [Related]
45. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
[TBL] [Abstract][Full Text] [Related]
46. Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise.
Christensen CK
Kidney Int; 1984 May; 25(5):819-23. PubMed ID: 6471668
[TBL] [Abstract][Full Text] [Related]
47. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
[TBL] [Abstract][Full Text] [Related]
48. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
[TBL] [Abstract][Full Text] [Related]
49. Increased metabolic turnover rate and transcapillary escape rate of albumin in long-term juvenile diabetics.
Parving HH; Rossing N; Sander E
Scand J Clin Lab Invest; 1975 Jan; 35(1):59-66. PubMed ID: 1129593
[TBL] [Abstract][Full Text] [Related]
50. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms.
Nosadini R; Velussi M; Brocco E; Abaterusso C; Piarulli F; Morgia G; Satta A; Faedda R; Abhyankar A; Luthman H; Tonolo G
Diabetes; 2005 Jan; 54(1):228-33. PubMed ID: 15616033
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
Mathiesen ER; Hommel E; Giese J; Parving HH
BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
[TBL] [Abstract][Full Text] [Related]
52. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy.
Passariello N; Sepe J; Marrazzo G; De Cicco A; Peluso A; Pisano MC; Sgambato S; Tesauro P; D'Onofrio F
Diabetes Care; 1993 May; 16(5):789-95. PubMed ID: 8495620
[TBL] [Abstract][Full Text] [Related]
53. Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men.
Pedrinelli R; Penno G; Dell'Omo G; Bandinelli S; Giorgi D; Di Bello V; Nannipieri M; Navalesi R; Mariani M
Hypertension; 1998 Aug; 32(2):318-23. PubMed ID: 9719061
[TBL] [Abstract][Full Text] [Related]
54. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
Nielsen SE; Persson F; Frandsen E; Sugaya T; Hess G; Zdunek D; Shjoedt KJ; Parving HH; Rossing P
Diabet Med; 2012 Aug; 29(8):e184-90. PubMed ID: 22268920
[TBL] [Abstract][Full Text] [Related]
55. Transcapillary escape rate and relative metabolic clearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus.
Bent-Hansen L; Feldt-Rasmussen B; Kverneland A; Deckert T
Diabetologia; 1987 Jan; 30(1):2-4. PubMed ID: 3569694
[TBL] [Abstract][Full Text] [Related]
56. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
57. Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy.
Myrup B; Rossing P; Jensen T; Parving HH; Hølmer G; Gram J; Kluft C; Jespersen J
Scand J Clin Lab Invest; 2001; 61(5):349-56. PubMed ID: 11569481
[TBL] [Abstract][Full Text] [Related]
58. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.
Sato A; Tabata M; Hayashi K; Saruta T
Clin Exp Nephrol; 2003 Sep; 7(3):215-20. PubMed ID: 14586718
[TBL] [Abstract][Full Text] [Related]
59. Pathophysiological aspects of edema formation in diabetic nephropathy.
Hommel E; Mathiesen ER; Aukland K; Parving HH
Kidney Int; 1990 Dec; 38(6):1187-92. PubMed ID: 2074660
[TBL] [Abstract][Full Text] [Related]
60. Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
Andersen S; Jacobsen P; Tarnow L; Rossing P; Juhl TR; Parving HH
Nephrol Dial Transplant; 2003 Feb; 18(2):293-7. PubMed ID: 12543883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
